EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische Studie

Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight

Linong Ji iD, Hongwei Jiang, Yan Bi, Hua Li, Junhang Tian, Dexue Liu, Yuzhu Zhao, Wei Qiu, Chongbing Huang, Lei Chen, Shao Zhong, Jie Han und 12 weitere

New England Journal of Medicine · 2025

DOI: 10.1056/nejmoa2411528 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, 2025. Verfasst von Linong Ji und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Glucagon-Like Peptide-1 Receptor Agonists, Obesity, Overweight. Die Arbeit wurde bisher 130-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Innovent Biologics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Obesity AgentsGlucagon-Like Peptide-1 Receptor AgonistsObesityOverweightReceptors, GlucagonAdolescentAdultAgedFemaleHumansMaleMiddle AgedYoung AdultBody Mass IndexDouble-Blind MethodDrug Administration ScheduleWeight LossDose-Response Relationship, DrugTreatment OutcomePeptidesEast Asian People

Substanzen

Anti-Obesity AgentsGlucagon-Like Peptide-1 Receptor AgonistsmazdutideReceptors, GlucagonPeptides

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing.
  • Department of Endocrinology, First Affiliated Hospital and Clinical Medicine College, Henan University of Science and Technology, Luoyang, China.
  • Department of Endocrinology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
  • Department of Cardiology, Zibo Municipal Hospital, Zibo, China.
  • Department of Endocrinology, Luoyang Third People's Hospital, Luoyang, China.
  • Department of Endocrinology, First Affiliated Hospital of Nanyang Medical College, Nanyang, China.

ORCID-Profile: Linong Ji

Förderung

  • Innovent Biologics

Zitieren

APA

Ji, L., Jiang, H., Bi, Y., Li, H., Tian, J., Liu, D., Zhao, Y., Qiu, W., Huang, C., Chen, L., Zhong, S., Han, J., Zhang, Y., Lian, Q., Yang, P., Lv, L., Gu, J., Liu, Z., Deng, H., …, & GLORY-1 Investigators (2025). Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2411528

Vancouver

Ji L, Jiang H, Bi Y, Li H, Tian J, Liu D, et al. Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight. New England Journal of Medicine. 2025. doi:10.1056/nejmoa2411528

BibTeX
@article{Ji2025,
  author = {Ji, Linong and Jiang, Hongwei and Bi, Yan and Li, Hua and Tian, Junhang and Liu, Dexue and Zhao, Yuzhu and Qiu, Wei and Huang, Chongbing and Chen, Lei and Zhong, Shao and Han, Jie and Zhang, Yawei and Lian, Qiufang and Yang, Ping and Lv, Lingchun and Gu, Jieyu and Liu, Zihan and Deng, Huan and Wang, Yanqi and Li, Li and Pei, Lijuan and Qian, Lei and GLORY-1 Investigators, GLORY-1 Investigators},
  title = {Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight},
  journal = {New England Journal of Medicine},
  year = {2025},
  doi = {10.1056/nejmoa2411528}
}
Kostenlos starten →